Biography
In 1998 Ivan Chekalnikov graduated from the Moscow aviation technology university majoring in the engineer on production of aviation engines and power stations.
Since 2011 was engaged in production of vaccines and business development in Russia of the Belgian company GlaxoSmithKline Biologicals (the portfolio of GSK includes the vaccines against hepatitis, chicken pox, Teraflyu and Koldreks cold remedies).
Then several years directed the production cluster merging assets in the territory of Russia, Ukraine and Belarus in Unilever company.
Since 2016 headed the production block of Nizhny Novgorod Oil and Fat Plant group (brands: Ryaba mayonnaise, margarine "Hostess", "Astoria") which included 12 production sites, group of purchases, department of a research and development, logistic department and service of quality.
In March, 2018 Ivan Chekalnikov headed biopharmaceutical company "Fort". To the CEO's positions he is responsible for development of the company, expansion of a product portfolio, development of production capacities and also participates in strategy formation.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |